NewAmsterdam Pharma (NAMS) EPS (Basic) (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted EPS (Basic) of -$0.4 for Q1 2026, up 37.09% sequentially from -$0.63 in Q4 2025, and down 16.92% YoY from -$0.48 in Q1 2025.
NewAmsterdam Pharma (NAMS) EPS (Basic) (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma has reported EPS (Basic) for 4 years, with the latest figure at -$0.4 in Q1 2026.
- Quarterly EPS (Basic) fell 16.92% year-over-year to -$0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.75 (down 8.33% YoY) and the FY2025 annual result came in at -$1.28, up 50.12% from the prior year.
- EPS (Basic) advanced to -$0.4 in Q1 2026 per NAMS's latest filing, from -$0.63 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.15 in Q2 2025 and troughed at -$1.06 in Q1 2024.
- A 4-year average of -$0.54 and a median of -$0.54 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 69.26% in 2024, then sank 244.41% in 2025.
- Over 4 years, EPS (Basic) stood at -$0.6 in 2023, then tumbled by 62.25% to -$0.98 in 2024, then jumped by 35.24% to -$0.63 in 2025, then surged by 37.09% to -$0.4 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.4, -$0.63, and -$0.61 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | NewAmsterdam Pharma | 3.17 Bn | 3.17 Bn | - | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.52 |
| Mar 31, 2026 | -0.40 |
| Dec 31, 2025 | -0.63 |
| Sep 30, 2025 | -0.61 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.34 |
| Dec 31, 2024 | -0.98 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.41 |
| Mar 31, 2024 | -1.06 |
| Dec 31, 2023 | -0.60 |
| Sep 30, 2023 | -0.57 |
| Mar 31, 2023 | -0.51 |